Skip to main content
AIMD
NASDAQ Life Sciences

Ainos Reveals $600K Upfront and 25% Sublicensing Cut in VELDONA Deal

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.32
Mkt Cap
$9.895M
52W Low
$1.25
52W High
$4.44
52W Position info
5.6% above low
Off High info
70% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AIMD is trading near its 52-week low of $1.25 (5.6% above the low).

Summary

Ainos disclosed the financial structure of its VELDONA license agreement with BioPhoenix, including a $600,000 initial fee payable within 15 business days, a 25% share of net sublicensing revenue, and a separate first-sublicense fee. The partner will fund and execute clinical and regulatory work for Sjögren's disease and thrombocytopenia, reducing Ainos' capital needs. The framework could reach $10 million across initial and additional indication licenses, with further upside from sublicensing and supply deals. This follows the September 24 announcement and adds concrete near-term cash and long-term participation terms. The company retains platform ownership and can pursue direct licenses for other indications.

At the time of this announcement, AIMD was trading at $1.32 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $9.9M. The 52-week trading range was $1.25 to $4.44. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

AIMD - Latest Insights

AIMD
Nov 20, 2026, 5:15 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.15
Real-time Price: $1.15 info
Change: $0 (0%) info
Market Cap: $8.927M info
AIMD
Nov 16, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.10
Real-time Price: $1.15 info
Change: +$0.050 (+5%) info
Market Cap: $8.927M info
AIMD
Nov 16, 2026, 8:41 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.32
Real-time Price: $1.15 info
Change: -$0.165 (-13%) info
Market Cap: $8.927M info
AIMD
Nov 16, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $1.30
Real-time Price: $1.15 info
Change: -$0.150 (-12%) info
Market Cap: $8.927M info
AIMD
Nov 12, 2026, 8:30 AM EST
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.520
Real-time Price: $1.15 info
Change: +$0.630 (+121%) info
Market Cap: $8.927M info